← Issue №19/ week of Nov 8, 2026/Pancreas/Biliary

Acid Suppression and Pancreatitis: Are PCABs Safer Than PPIs? A Global Database Analysis.

From GI Signals issue №19: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Pancreas/Biliary retrospective · n=13,574,975 · Nov 3, 2026 · J Clin Gastro · IF 2.9

Acid Suppression and Pancreatitis: Are PCABs Safer Than PPIs? A Global Database Analysis.

Practice-changingacute pancreatitisepidemiology
Clinical takeawayNo clinical action yet: pancreatitis risk did not differ significantly, and the lower odds of respiratory failure, renal failure, sepsis and death with PCABs come from a retrospective database cohort.
What it foundPCAB use was not associated with a statistically significant difference in new-onset AP compared with PPI (OR: 0.624; P=0.24), with AP incidence of 0.65% vs 0.96% within 90 days.
ContextTriNetX cohort of 77,841 PCAB and 13.5 million PPI users, propensity matched.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Sunkesula V … Waghray N · Journal of Clinical Gastroenterology · IF 2.9 · PubMed ↗Permalink
← Read the whole of issue №19 Every paper GI Signals surfaces gets a page like this one. All issues